Release Date: 26/09/19 08:41 Summary: ResAppDx-EU for Adult Respiratory Disease Receives CE Mark Price Sensitive: Yes Download Document 81.44KB Download
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”